Laboratory Services

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Spike Antibody, Semi-Quantitative, Serum

Print this page

Updated Test Information:

Test Description
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Spike Antibody, Semi-Quantitative, Serum
Synonym(s)

Coronavirus, Coronavirus Ab, Coronavirus antibody, COVID-19 Ab, COVID-19, COVID-19 antibody, SARS CoV-2 Ab, SARS CoV-2, SARS CoV-2 antibody

Test ID
COVSQ
General Information

Aiding in the identification of individuals with an adaptive immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), indicating prior infection or vaccination


Manufacture of coronavirus disease 2019 (COVID-19) convalescent plasma


This test provides semi-quantitative detection of serum antibodies against the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19).


This test is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating prior infection and/or vaccination.

Container Type

SST or Red top

Specimen Type

Serum

Specimen Requirements

Preferred: Serum gel
Acceptable: Red top
Specimen Volume: 1 mL

Specimen Collection / Processing Instructions

SST - Separate serum or plasma from cells within 45 minutes of collection.


Red top: Centrifuge and remove serum from red blood cells within 2 hours of draw. Aliquot serum to submission container (plastic vial).

Stability

Refrigerated (preferred): 7 days
Room Temperature: 72 hours
Frozen: 28 days

Unacceptable Specimen Conditions

Improper labeling, quantity not sufficient, improper collection container, gross hemolysis

Methodology

Electrochemiluminescence Immunoassay (ECLIA) 

Estimated TAT

1-3 days

Testing Schedule

Monday - Saturday

Test Includes

SARS-CoV-2 Spike Ab, Semi-Quant, S

CPT Code(s)

86769

Minimum Sample Volume

0.75mL

Reference Range

Negative

Performing Lab

Mayo Clinic

LOINC Code(s)

94769-7